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ABSTRACT 
 
Our appreciation of the role of human-associated microbial communities in the context of 
human health and disease has grown dramatically in the past two decades, with modern 
research tools enabling deeper insights into the mechanisms of host-microbial interactions. 
The elusive notion of dysbiosis, a state of microbial imbalance related to a disease, has 
achieved widespread distribution across popular, scientific, and medical literature (on 
September 16, 2019 PubMed search yielded 6,064 records of scientific and medical 
publications containing this keyword). The conventional wisdom further narrows down the 
definition and understanding of dysbiosis towards a compositional “imbalance” of the 
microbiota (a community of microorganisms inhabiting the human body). There exists an 
additional and frequently overlooked aspect of microbial imbalance in the context of the 
human gastrointestinal system, something that we can define as a “spatial imbalance”: a state 
of the microbial community in the host gastrointestinal system where even a “healthy” and 
“balanced” microbiota may be associated with or causative of a disease by being present in 
sections of the gastrointestinal tract where it is not “supposed” to be, with the most prominent 
example being small intestinal bacterial overgrowth (SIBO). This thesis describes the 
progress in the development of analytical tools (quantitative microbiome profiling described 
in Chapter I) and refinement of animal mouse models (non-coprophagic mouse model 
described in Chapter II) for exploring the normal function of small-intestine microbiota in 
health and for dissecting the mechanisms of emergence and the persistence of the small-
intestine dysbiosis (SIBO) in the future.  
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C h a p t e r  1  
QUANTITATIVE MICROBIOME PROFILING IN LUMENAL AND 
TISSUE SAMPLES WITH BROAD COVERAGE AND DYNAMIC 
RANGE VIA A SINGLE ONE-STEP 16S RIBOSOMAL RNA GENE 
DNA COPY QUANTIFICATION AND AMPLICON BARCODING 
Said R. Bogatyrev and Rustem F. Ismagilov 
ABSTRACT 
Current methods for detecting, accurately quantifying, and profiling complex microbial 
communities based on the microbial 16S rRNA marker genes are limited by a number of 
factors, including inconsistent extraction of microbial nucleic acids, amplification 
interference from contaminants and host DNA, different coverage of PCR primers utilized 
for quantification and sequencing, and potentially biases in PCR amplification rates among 
microbial taxa during amplicon barcoding. Here, we describe a method that enables the 
quantification of microbial 16S rRNA gene DNA copies with wide dynamic range and broad 
microbial diversity, and simultaneous amplicon barcoding for quantitative  profiling of 
microbiota based on 16S rRNA gene amplicon sequencing. The method is suitable for a 
variety of sample types and is robust in samples with low microbial abundance, including 
samples containing high levels of host mammalian DNA, as is common in human clinical 
samples. We demonstrate that our modification to the Earth Microbiome Project (EMP) V4 
16S rRNA gene primers expands their microbial coverage while dramatically reducing non-
specific mammalian mitochondrial DNA amplification, thus achieving wide dynamic range 
in microbial quantification and broad coverage for capturing high microbial diversity in 
samples with or without high host DNA background. The approach relies only on broadly 
available hardware (real-time PCR instruments) and standard reagents utilized for 
conventional 16S rRNA gene amplicon library preparation. Simultaneous 16S rRNA gene 
DNA copy quantification and amplicon barcoding for multiplexed next-generation 
sequencing from the same analyzed sample, performed in a combined workflow, reduces 
time and reagent costs, all of which make the approach amenable for immediate and 
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widespread adoption. Additionally, we demonstrate that using our modified 16S rRNA gene 
primers in a digital PCR (dPCR) format enables precise and exact microbial quantification 
in samples with very high host DNA background levels without the need for quantification 
standards. Potential future applications of this approach include: (1) quantitative microbiome 
profiling in human and animal microbiome research; (2) detection of monoinfections and 
profiling of polymicrobial infections in tissues, stool, and bodily fluids in human and 
veterinary medicine; (3) environmental sample analyses (e.g., soil and water); and (4) broad-
coverage detection of microbial food contamination in products high in mammalian DNA, 
such as meats. We predict that utilization of this approach primarily for quantitative 
microbiome profiling will be invaluable to microbiome studies, which have historically been 
limited to analysis of relative abundances of microbes. 
 
INTRODUCTION 
Microbiome analysis has emerged as a prominent research field to improve our 
understanding of the host-microbiota interactions linked to human disease. Utilization of 
high-throughput next generation sequencing (NGS) technology in combination with 
microbial marker gene sequencing (e.g., microbial 16S rRNA gene) has enabled high-
diversity and high-depth compositional analyses of microbiomes. NGS-based compositional 
analyses (relative abundances of the microbiome elements) have dominated the field since 
their emergence. The limitations of compositional analyses have been gaining broader 
acknowledgement in the field and a number of quantitative microbiome profiling approaches 
have been proposed as promising tools for solving the shortcomings of purely compositional 
analyses. Current quantitative analysis approaches have important limitations: (i) high levels 
of host DNA interfere with the amplification of target microbial sequences, (ii) coverage of 
microbial taxa is limited, and (iii) relative quantification cannot provide a complete picture 
of changes in microbial taxa. 
Here, to address the aforementioned limitations of current quantitative analysis methods, we 
describe an approach that allows simultaneous (with one sample) determination of the 
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absolute 16S rRNA gene DNA copy loads with broad dynamic range and enables wide-
diversity microbiome profiling in a simplified and broadly-adoptable workflow (Fig. 1). The 
proposed approach for quantitative 16S rRNA gene amplicon profiling is based on the 
combination of absolute 16S rRNA gene DNA copy quantification and 16S rRNA gene 
amplicon sequencing utilizing a real-time PCR amplification readout and amplicon 
barcoding for NGS performed for the variable V4 region of the prokaryotic 16S rRNA gene 
sequence amplicon. 
This approach is optimized for use in samples with high and low levels of mammalian (e.g., 
mouse) host DNA which enables quantitative 16S rRNA gene amplicon sequencing of 
clinical samples, such as stool, gastrointestinal contents or lavage fluid, and mucosal 
biopsies. 
“One-step” approach includes the following workflow steps: 
A. Total DNA is extracted and purified from such samples using commercially-
available kits (Fig. 1A) validated for uniform DNA extraction from complex 
microbiota [e.g., ZymoBIOMICS] and for quantitative recovery of microbial DNA 
from samples with microbial loads across multiple orders or magnitude (Fig. S1). 
B. PCR reactions are set up using the improved 16S rRNA gene primers and 
conventional commercial reagents for 16S rRNA gene amplicon library preparation 
together with the universal 16S rRNA gene primers containing barcodes and 
Illumina adapters (Fig. 1B). Reactions are replicated to improve the real-time PCR 
quantification precision and resolution and amplicon barcoding uniformity [1]. 
C. Amplification and barcoding of the V4 region of the microbial 16S rRNA gene DNA 
are performed under real-time fluorescence measurements on a real-time PCR 
instrument (Fig. 1C). We define this approach as “barcoding qPCR” or “BC-qPCR”. 
Real-time fluorescence monitoring enables terminating the amplification of each 
sample upon reaching the mid-exponential phase to maximize the amplicon yield 
and minimize the overamplification artifacts [2]. 
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D. Quantitative real-time PCR data (Cq values) are recorded (Fig. 1D) and used to 
calculate the absolute concentration of the 16S rRNA gene DNA copies in each 
sample (based on the 16S rRNA gene copy standards included within the same BC-
qPCR run) or to calculate the absolute fold-differences in the 16S rRNA gene DNA 
copy load among the samples (in the absence of the standards).These data are further 
used to calculate the absolute microbial abundances in the analyzed samples. 
E. Barcoded 16S rRNA gene DNA amplicon samples are quantified, pooled, purified, 
and sequenced on an NGS instrument. 
F. NGS sequencing results provide the sequence read and count data from which the 
microbial identity and relative abundances of the microbial taxa are estimated (Fig. 
1F). 
G. Microbiota relative abundance profiles (from step “F”) are converted to microbiota 
absolute or absolute fold-difference abundance profiles using the absolute or 
absolute fold-difference data on 16S rRNA gene DNA loads in the corresponding 
samples (as measured in the step “D”) (Fig. 1G). 
To achieve the desired broad dynamic range and coverage of the quantitative 16S rRNA gene 
amplicon sequencing and its robust performance in samples with high or low host DNA 
background, we (I) modified the universal 16S rRNA gene primers for gene-copy 
quantification in qPCR and ddPCR assays and amplicon barcoding in BC-qPCR with high 
specificity against host DNA; (II) optimized the BC-qPCR parameters to minimize primer 
dimer formation and host DNA amplification while reducing amplification biases and 
ensuring uniform amplification of diverse 16S rRNA gene sequences from complex 
microbiomes; and (III) validated the accuracy of the quantitative 16S rRNA gene amplicon 
sequencing obtained using the “one-step” BC-qPCR approach compared with the 
quantitative 16S rRNA gene amplicon sequencing  results obtained using real-time and 
digital PCR. 
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Fig. 1. Schematic of the “one-step” 16S rRNA gene DNA quantification and amplicon 
barcoding workflow (“BC-qPCR”) implementation for quantitative microbiome 
profiling. (A) Sample collection and DNA extraction. (B) BC-qPCR reactions are prepared 
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in replicates for more accurate quantification and uniform amplicon barcoding. (C) 
Amplification and barcoding are performed under real-time fluorescence measurements on 
a real-time PCR instrument. (D) Quantitative PCR data (Cq values) are recorded. (E) 
Barcoded samples are quantified, pooled, purified, and sequenced on an NGS instrument. 
(F) NGS sequencing results provide data on relative abundances of microbial taxa. (G) 
Microbiota relative abundance profiles are converted to microbiota absolute or absolute fold-
difference abundance profilies using the absolute or absolute fold-difference data on 16S 
rRNA gene DNA loads in the corresponding samples measured in step (D). 
 
RESULTS 
Optimized primers improve broad-coverage 16S rRNA gene DNA quantification via real-
time and digital PCR in the presence of high host DNA background 
We first aimed to adapt the Earth Microbiome Project (EMP) 16S rRNA gene amplicon 
sequencing protocol [1], [3] for quantitative microbiota profiling. This protocol is well-
known for having broad microbial coverage and has been widely adopted in the field of basic 
and clinical microbiome research. We hypothesized that by redesigning the EMP forward 
primer (designated by us as UN00F0) at its 5′ end to start at the position 519 (UN00F2) of 
the V4 region of microbial 16S rRNA gene sequence (Fig. 2A) we would either reduce or 
eliminate its nonspecific annealing to the mouse and human mitochondrial 12S rRNA gene 
DNA. Such change would increase the primer’s specificity for low copy number microbial 
templates in samples with high content of mouse or human host DNA background. We 
confirmed the effectiveness of these design considerations by performing qPCR reactions in 
complex mouse microbiota DNA samples analyzed neat or spiked in with GF mouse small-
intestine mucosal DNA at 100 ng/uL. The ~200-bp mithochondrial amplicons were absent 
in the PCR reactions containing high amounts of mouse DNA and using the modified 
forward primer UN00F2 (Fig. 2B). 
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The efficiency of the quantitative PCR reactions set up with the modified forward primer 
UN00F2 was similar (and high) with and without the presence of 100 ng/µL of mouse DNA 
in the template sample (Fig. 2C) demonstrating the robust assay performance. 
Our qPCR experiments also suggested that the PCR reactions with high host DNA 
background are intercalating dye-limited: the increase in total fluorescence (∆-RFU) in each 
reaction at the end of amplification was lower in samples containing 100 ng/µL of 
background mouse DNA whereas the total fluorescence levels were similar between samples 
with and without the background mouse DNA. By combining the use of the new forward 
primer UN00F2 with the supplementation of commercial reaction mix with additional 
amounts of intercalating EvaGreen dye improved the digital PCR performance by increasing 
the separation between negative and positive droplets in the droplet digital PCR (ddPCR) 
reactions used for quantifying 16S rRNA gene DNA copies in samples with high host DNA 
background (100 ng/uL) (Fig. 2D). This assay was used to establish or confirm the exact 16S 
rRNA gene DNA copy numbers in the standard samples, which were further utilized to build 
the standard curves in the qPCR assays. 
Additionally, the modification of the primer set UN00F2 + UN00R0 broadened its 
taxonomical coverage of the microbial diversity (86.0% Archaea, 87.0% Bacteria) compared 
with the original EMP primer set UN00F0 + UN00R0 (52.0% Archaea, 87.0% Bacteria) 
based on the SILVA reference database [4], [5]. 
 
Modified barcoded primers and optimized workflow enable simultaneous 16S rRNA gene 
DNA copy quantification and amplicon barcoding in samples with high host DNA 
background 
We next aimed to evaluate whether the barcoded UN00F2 + UN00R0 primer set would allow 
the amplification and amplicon barcoding of specific microbial 16S rRNA gene DNA 
template in the presence of high host DNA background. It is important to note the two 
essential design principles in the BC-qPCR reaction optimization that guided our work: 
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1. The amplification and barcoding reaction should be conducted at the lowest possible 
annealing temperature to maximize the uniformity of amplification of the diverse 16S 
rRNA gene DNA sequences with degenerate primers (both original and improved 
EMP) and eliminate the amplification biases. 
2. The amplification and barcoding reaction should be conducted at the highest possible 
annealing temperature to minimize the primer dimer formation and non-specific host 
mitochondrial DNA amplification both of which would be competing with specific 
microbial 16S rRNA gene DNA template for reaction resources (dNTPs, primers, 
polymerase, intercalating dye). Such competing reactions would inevitably have 
pronounced effects on the samples containing very low levels of specific microbial 
template and requiring high numbers of amplification cycles. 
 
 
9 
 
Fig. 2. Optimization of the protocol for microbial 16S rRNA gene DNA copy 
quantification in samples without and with high mammalian DNA background. (A) 
Sequence alignment of the original EMP and modified forward primers targeting the V4 
region of microbial 16S rRNA gene are shown with the E. coli 16S rRNA gene and mouse 
and human mitochondrial 12S rRNA gene. (B) Amplification products of the complex 
microbiota DNA sample containing 100 ng/uL of GF mouse DNA with the original EMP 
and modified forward primers. (C) Quantitative PCR reaction performance with the serial 
10-fold dilutions of the complex microbiota DNA sample with and without 100 ng/µL of 
mouse DNA. (D) Improvement of the 16S rRNA gene DNA copy ddPCR quantification 
assay performance in the presence of 100 ng/µL of mouse DNA background as a result of 
the supplementation of intercalating dye to the commercial droplet digital PCR (ddPCR) 
master mix. 
 
Compared with the improved primer set (UN00F2 + UN00R0), the original EMP primer set 
(UN00F0 + UN00R0) requires a higher annealing temperature to reduce primer dimer 
formation and amplification of mouse mitochondrial (MT) DNA. Long “overhangs” 
(carrying the linker and Illumina adapter sequences) at the 5′ end of the forward primer and 
non-complimentary to the specific 16S rRNA gene DNA template were not sufficient to 
prevent the EMP primer set from amplifying the mouse MT DNA. At 54 °C both primer 
dimers and MT DNA amplification persisted in the reactions using the EMP primers, which 
suggested that this primer set would require even higher annealing temperatures (>54 °C) to 
eliminate the amplification artifacts. This in turn will likely introduce amplification biases 
across a range of specific 16S rRNA gene DNA templates. Using the improved primer set 
eliminated both artifacts in the reactions conducted at 54 °C (Fig. 3A), while some primer 
dimer formation was still present in the reactions conducted at 52 °C. Thus, the temperature 
of 54 °C was selected as optimal for the BC-qPCR reaction. 
We next confirmed that the BC-qPCR reaction can provide accurate quantification data for 
the amount of 16S rRNA gene DNA copy loads in the analyzed samples. The Cq values 
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obtained based on the real-time fluorescence measurements during the BC-qPCR reaction 
were in good agreement with the absolute 16S rRNA gene DNA copy values (Fig. 3B) 
estimated in the same samples using the previously optimized qPCR assay (Fig. 2C). 
 
 
Fig. 3. Optimization of the “one-step” protocol for microbial 16S rRNA gene DNA copy 
quantification and amplicon barcoding in samples without and with high mammalian 
DNA background. (A) Amplification products of the complex microbiota DNA sample 
containing 100 ng/µL of GF mouse DNA with the barcoded original EMP (UN00F0 + 
UN00R0) and barcoded modified (UN00F2 + UN00R0) primer sets. (B) Correlation of the 
BC-qPCR Cq values (Y-axis) with the absolute 16S rRNA gene DNA copy numbers (X-
axis) previously determined in the same set of samples (with and without high host DNA 
background) using the UN00F2 + UN00R0 qPCR assay. 
 
One-step approach enables absolute or absolute fold-change microbiota profiling 
To evaluate the accuracy of the absolute abundances or absolute abundance fold-differences 
estimated using the “one-step” approach, the BC-qPCR data were validated against the 
absolute abundances previously obtained using a two-step approach (Fig. 4) on the same set 
of samples [6]. The BC-qPCR approach provides the fold-differences in absolute microbial 
11 
 
abundances among samples even in the absence of the exact microbial load estimates (i.e., 
when no standard curve is available). 
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Fig. 4. Exploratory 16S rRNA gene amplicon sequencing data analysis of the absolute 
complex microbiota profiles (in samples from [6]) obtained using the standard 
quantification and sequencing approach or using the “one-step” approach. (A) Principal 
component analysis (PCA) of the absolute (left), estimated using the multistep approach, and 
13 
 
absolute fold-difference (right) microbiome profiles, obtained using the “one-step” approach 
with the assumed BC-qPCR efficiency of 85.0%. (B) Principal coordinate analysis (PCoA) 
of the Bray-Curtis dissimilarity matrices obtained for the same types of data as in panel (A). 
All values were multiplied by 102 to ensure the log10-transformed values of the non-anchored 
absolute abundances obtained from the BC-qPCR were greater than zero (> 0). 
 
CONCLUSIONS 
The “one-step” BC-qPCR approach enables accurate quantification of the number of 16S 
rRNA DNA gene copies and unbiased absolute abundance profiling of the microbial 
community structure in samples with microbial loads varying across multiple orders of 
magnitude and containing high host DNA background. The BC-qPCR approach offers the 
following advantages over the methods currently used in the field: 
 Broader coverage of microbial diversity (87% bacteria, 87% of archaea based on the 
16S rRNA marker gene sequences [4], [5]) maximizes the completeness of microbial 
detection and quantification and richness of diversity profiling. 
 Microbial 16S rRNA gene DNA copy quantification demonstrated a broad dynamic 
range: the lower limit of quantification (LLOQ) – ~104.83 copies/mL and the, upper 
limit of quantification (ULOQ) – ~1010.95 copies/mL. 
 Quantification has high resolution – ~1.25-1.67-fold differences in absolute 16S 
rRNA gene DNA copy concentrations can be distinguished in the demonstrated 
dynamic range with and without high host DNA background (100 ng/uL). 
 “What's quantifiable – is sequenceable, what's sequenceable – is quantifiable”: our 
method maximizes correspondence between the total 16S rRNA gene DNA copy 
quantification data and 16S rRNA gene amplicon sequencing profiling data as a 
major advantage over the currently implemented approaches [7]–[11]. 
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 Primer design allows for a good 16S rRNA gene DNA real-time (quantitative) PCR, 
digital PCR, and amplicon barcoding PCR reaction performance in samples with high 
mammalian host DNA background. No host DNA depletion is required for accurate 
microbial quantification and profiling, which is an advantage over the methods 
currently implemented in the field. 
 Optimized “one-step” 16S rRNA gene DNA amplicon barcoding and quantification 
approach (performed in a single PCR reaction instead of two separate PCR reactions 
for quantification and barcoding) reduces the reagent and time costs while providing 
richer absolute or fold-difference microbiota profiles of the analyzed samples. 
 Optimized amplicon barcoding PCR reaction chemistry and workflow prevent 
amplification artifacts and biases [2] that could affect the accuracy of relative 
abundance measurements across samples with broad range of microbial loads and 
thus requiring different numbers of amplification cycles. 
 The approach eliminates the need in synthetic spike-ins for accurate quantitiative 16S 
rRNA gene amplicon sequencing. Easily accessible commercial microbiome 
standards (e.g., ZymoBIOMICS) can be integrated as quantitative standards in the 
proposed protocol. 
 The approach may be applicable in both single (described in this report) and dual-
indexing workflows. 
 Overall, the proposed “one-step” approach for quantitative 16S rRNA gene amplicon 
sequencing based on the conventional real-time (quantitative) qPCR workflow 
allows for broad and immediate adoption of the approach in the field of basic and 
clinical microbiome research.  
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METHODS 
For methods please refer to the “METHODS” section of the Chapter 2 of this dissertation 
and in [6]. 
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C h a p t e r  I I  
SELF-REINOCULATION WITH FECAL FLORA CHANGES 
MICROBIOTA DENSITY AND COMPOSITION LEADING TO AN 
ALTERED BILE-ACID PROFILE IN THE MOUSE SMALL INTESTINE 
Said R. Bogatyrev, Justin C. Rolando, and Rustem F. Ismagilov 
ABSTRACT 
Alterations to the small-intestine microbiome are implicated in various human diseases, yet 
the physiological and functional roles of the small-intestine microbiota remain poorly 
characterized because of sampling complexities. Murine models enable spatial, temporal, 
compositional, and functional interrogation of the gastrointestinal microbiota, however fecal 
microbial self-reinoculation (via coprophagy, ubiquitous among rodents) can affect the 
structure and function of microbiota in the upper gut. Using quantitative 16S rRNA gene 
amplicon sequencing, quantitative microbial functional gene content inference, and targeted 
metabolomics, we found that self-reinoculation had profound quantitative and qualitative 
effects on the mouse small-intestine microbiota, which led to altered bile-acid profiles. The 
patterns observed in the small intestine of non-coprophagic mice (reduced total microbial 
load, low abundance of anaerobic microbiota, and bile acids predominantly in the conjugated 
form) resemble those typically seen in the human small intestine. The implications of our 
study are likely to be important for future research using mouse models to evaluate 
gastrointestinal microbial colonization and function in the context of bile-acid and xenobiotic 
metabolism, diet and probiotics research, and diseases related to small-intestine dysbiosis. 
 
INTRODUCTION 
The small intestine is the primary site for enzymatic digestion and nutrient uptake, immune 
sampling, and drug absorption in the human gastrointestinal system. Its large surface area 
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vastly exceeds that of the large intestine [12], and thus may serve as a broad interface for 
host-microbial interactions. 
A growing body of scientific evidence highlights the importance of the small-intestine 
microbiome in normal human physiology and response to dietary interventions [13], [14]. 
Alterations in the small-intestine microbiome are implicated in a number of human disorders, 
such as malnutrition [15], [16], obesity, and metabolic disease [17], inflammatory bowel 
disease (IBD) and irritable bowel syndrome (IBS) [18]–[20], and drug side effects [21]. 
Despite the apparent importance of the small-intestine microbiome in human health, it 
remains understudied and poorly characterized largely because of the procedural and 
logistical complexities associated with its sampling in humans (methods are too invasive and 
require specialized healthcare facilities). Moreover, microbial composition tends to differ 
substantially among the small intestine, large intestine, and stool of the same animal or 
human subject [22], [23], which highlights the importance of targeted sampling of the small 
intestine for analyses. 
Mice are the predominant animal species of model organisms in the field of microbiome 
research. Compared with other mammalian models, mice have a lower cost of maintenance, 
their environment and diet can be easily controlled, they are amenable to genetic 
manipulation, there are numerous genetic mouse models already available, and propagation 
using inbred colonies reduces inter-individual variability [24]. Additionally, murine germ-
free (GF) and gnotobiotic technologies are well established. Using mouse models enables 
interrogation of the entire gastrointestinal tract (GIT) and examination of the changes in 
microbiome and host physiology that occur in response to experimental conditions (e.g., 
dietary modifications, xenobiotic administration, etc.) or microbial colonization (e.g., 
monocolonization, colonization with defined microbial consortia, human microbiota-
associated mice, etc.). 
Rodent models also have several well-recognized limitations associated with their genetic, 
anatomical, and physiological differences with humans [24], [25]. Among these limitations 
is the persistent tendency of rodents to practice gastrointestinal auto- and allo-reinoculation 
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with large-intestine microbiota (via fecal ingestion, or coprophagy) in laboratory settings 
[26]–[28]. This pervasive behavior has been documented in classical studies using 
observational techniques in both conventional and GF mice [29], in conventional mice 
maintained on standard and fortified diets [30], in animals with and without access to food 
[31], and across different mouse strains [27], [32].  
Multiple classical studies have attempted to evaluate the effects of self-reinoculation on the 
structure of the microbiota in the rodent small intestine [33]–[35] and large-intestine and 
stool [31], [34], [36], [37] using traditional microbiological techniques, but reported 
conflicting results [34], [36], [37]. This lack of consensus may be attributed to the use of 
different methods for preventing coprophagy (some of which are ineffective), non-
standardized diets, inter-strain or inter-species differences among the animal models, or other 
unaccounted for experimental parameters. It has been also suggested that repeated self-
exposure in mice via coprophagy can promote microbial colonization of the GIT by 
“exogenous” microbial species, such as Pseudomonas spp. [38]. All of these observations 
highlight the importance of considering self-reinoculation in studies of gastrointestinal 
microbial ecology in murine models. However, the field currently lacks precise and 
comprehensive evaluations of the effects of self-reinoculation on the spatial, structural, and 
functional state of the gut microbiome and its effects on murine host physiology. Current 
microbiome studies in rodents either do not take self-reinoculation into account, or assume 
it can be eliminated by single housing of animals or housing them on wire mesh floors (also 
referred to as “wire screens” or “wire grids”) [25]. Despite classical literature suggesting 
these assumptions can be incorrect [27], [32], [39]–[43], they have not been tested on mice 
housed in modern facilities using state-of-the-art quantitative tools. 
Here, we explicitly test these assumptions about murine self-reinoculation to answer the 
following three questions relevant to gastrointestinal microbiome research: (1) Do 
quantitative 16S rRNA gene amplicon sequencing tools detect differences in small-intestine 
microbial loads between mice known to be coprophagic and non-coprophagic? (2) Does 
coprophagy impact the microbial composition of the small intestine? (3) Do differences in 
microbiota density and composition associated with self-reinoculation in mice impact the 
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microbial function (e.g., alter microbial metabolite production or modifications) in the small 
intestine? 
To answer these questions, we analyzed gastrointestinal samples from mice under conditions 
known to prevent coprophagy (fitting with “tail” or “fecal collection” cups [27], [34], [37], 
[41], [44]) and typical laboratory conditions in which mice are known to be coprophagic 
(housing in standard cages). We also included samples from single-housed mice in standard 
and wire-floor cages. We analyzed the quantitative and compositional changes in the 
microbiome along the entire length of the mouse GIT in response to self-reinoculation, 
computationally inferred the changes in microbial function, and evaluated the microbial 
function-related metabolite profiles in the corresponding segments of the gut. 
 
RESULTS 
We first performed a pilot study to confirm that preventing coprophagy in mice would result 
in decreased viable microbial load and altered microbiota composition in the small intestine. 
We used a most probable number (MPN) assay utilizing anaerobic BHI-S broth medium to 
evaluate the live (culturable) microbial loads along the entire GIT of mice known to be 
coprophagic (housed in standard cages in groups, N = 5) and mice known to be non-
coprophagic (fitted with tail cups and housed in standard cages in groups, N = 5). Consistent 
with the published, classical literature [31], [35], we found that coprophagic mice had 
significantly higher loads of culturable microbes in their upper GIT than mice that were non-
coprophagic (Fig. S4A). Moreover, the microbial community composition in the proximal 
GIT, particularly in the stomach, of coprophagic mice more closely resembled the microbial 
composition of the large intestine (Fig. S4B) as revealed by 16S rRNA gene amplicon 
sequencing (N = 1 mouse analyzed from each group) and principal components analysis 
(PCA) of the resulting relative abundance data. 
This pilot study confirmed that in our hands tail cups were effective at preventing the self-
reinoculation of viable fecal flora in the upper GIT of mice. These results spurred us to design 
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a rigorous, detailed study (Fig. 1) to answer the three questions posed above using state-of-
the-art methods: quantitative 16S rRNA gene amplicon sequencing (to account for both 
changes in the total microbial load and the unculturable taxa), quantitative functional gene 
content inference, and targeted bile-acid metabolomics analyses. 
The study design (Fig. 1) consisted of six cages of four animals each that were co-housed for 
2-6 months and then split into four experimental groups and singly housed for 12-20 days. 
The four experimental conditions were: animals fitted with functional tail cups (TC-F) and 
singly housed in standard cages, animals fitted with mock tail cups (TC-M) and singly 
housed in standard cages, animals singly housed on wire floors (WF), and control animals 
singly housed in standard conditions (CTRL). At the end of the study, gastrointestinal 
contents and mucosal samples were collected from all segments of the GIT of each animal 
and we evaluated total microbial loads (entire GIT) and microbiome composition (stomach 
(STM), jejunum (SI2), and cecum (CEC)). 
 
21 
 
 
Fig. 2.1. An overview of the study design and timeline. (A) Mice from two age cohorts (3-
months-old and 7-months-old) were raised co-housed (four mice to a cage) for 2-6 months. 
One mouse from each cage was then assigned to one of the four experimental conditions: 
(functional tail cups (TC-F), mock tail cups (TC-M), housing on wire floors (WF), and 
controls housed in standard conditions (CTRL). All mice were singly housed and maintained 
on each treatment for 12-20 days (N = 24, 6 mice per group). (B) Samples were taken from 
six sites throughout the gastrointestinal tract. Each sample was analyzed by quantitative 16S 
rRNA gene amplicon sequencing of lumenal contents (CNT) and mucosa (MUC) and/or 
quantitative bile-acid analyses of CNT. Panel B is adapted from [24], [45]). 
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We chose the cecum segment of the large intestine for quantitative 16S rRNA gene amplicon 
sequencing because the analysis of the contents of this section can provide a complete 
snapshot of the large-intestine and fecal microbial diversity in response to environmental 
factors [46]–[48]. Cecal contents also enabled us to collect a more consistent amount of 
sample from all animals across all experimental conditions (whereas defecation may be 
inconsistent among animals at the time of terminal sampling). 
 
Self-reinoculation increases microbial loads in the upper gut 
To answer our first question (Can quantitative sequencing tools detect the difference in 16S 
rRNA gene DNA copy load in the upper GIT of mice known to be coprophagic and non-
coprophagic?), we analyzed total quantifiable microbial loads across the GIT using 16S 
rRNA gene DNA quantitative PCR (qPCR) and digital PCR (dPCR). Preventing self-
reinoculation in mice equipped with functional tail cups dramatically decreased the lumenal 
microbial loads in the upper GIT but not in the lower GIT (Fig. 2A). Total quantifiable 
microbial loads in the upper GIT were reduced only in mice equipped with functional tail 
cups. All other experimental groups of singly-housed animals (those equipped with mock 
tail cups, housed on wire floors, or housed on standard woodchip bedding) that retained 
access to fecal matter and practiced self-reinoculation had similarly high microbial loads in 
the upper GIT, as expected from the published literature [27], [32], [39]–[43]. 
Across all test groups, mucosal microbial loads in the mid-small intestine demonstrated high 
correlation (Pearson’s R = 0.84, P = 2.8 × 10-7) with the microbial loads in the lumenal 
contents (Fig. 2B). 
Stomach (STM) and small-intestine (SI1, SI2, and SI3) samples from one (out of six) of the 
TC-F mice showed higher microbial loads compared with the other TC-F mice. The total 
microbial load in the upper GIT in this TC-F mouse was similar to mice from all other groups 
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(TC-M, WF, CTRL), which emphasizes the crucial importance of performing analyses of 
both microbial load and composition (discussed below) on the same samples. 
 
 
Fig. 2.2. Quantification of microbial loads in lumenal contents and mucosa of the 
gastrointestinal tracts (GIT) of mice in the four experimental conditions: (functional 
tail cups (TC-F), mock tail cups (TC-M), housing on wire floors (WF), and controls 
housed in standard conditions (CTRL). (A) Total 16S rRNA gene DNA copy loads, a 
proxy for total microbial loads, were measured along the GIT of mice of all groups (STM = 
stomach; SI1 = upper third of the small intestine (SI), SI2 = middle third or the SI, SI3 = 
lower third of the SI roughly corresponding to the duodenum, jejunum, and ileum 
respectively; CEC = cecum; COL = colon). Multiple comparisons were performed using a 
Kruskal–Wallis test, followed by pairwise comparisons using the Wilcoxon–Mann–Whitney 
test with false-discovery rate (FDR) correction. Individual data points are overlaid onto box-
and-whisker plots; whiskers extend from the quartiles (Q2 and Q3) to the last data point 
within 1.5 × interquartile range (IQR). (B) Correlation between the microbial loads in the 
lumenal contents (per g total contents) and in the mucosa (per 100 ng of mucosal DNA) of 
the mid-SI. N = 6 mice per experimental group. 
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Self-reinoculation substantially alters the microbiota composition in the upper gut but has 
less pronounced effects in the large intestine 
To answer our second question (does self-reinoculation with fecal microbiota impact upper 
GIT microbial composition?), we performed quantitative 16S rRNA gene amplicon 
sequencing [49], [50] on stomach (STM), jejunum (SI2), and cecum (CEC) samples. 
Qualitative sequencing revealed dramatic overall changes in the upper GIT microbiota 
caused by self-reinoculation (Fig. 3). An exploratory PCA performed on the 
multidimensional absolute microbial abundance profiles highlights the unique and distinct 
composition of the upper GIT microbiome of non-coprophagic mice (Fig. 3A). It is 
noteworthy that the stomach (STM) and small-intestine (SI2) microbiota in all coprophagic 
mice clustered closer to the large-intestine microbiota, suggesting the similarity was due to 
persistent self-reinoculation with the large-intestine microbiota (Fig. 3A). 
Self-reinoculation had differential effects across microbial taxa (Fig. 3C), which could be 
classified into three main categories depending on the pattern of their change: 
1. “Fecal taxa” (e.g., Clostridiales, Bacteroidales, Erysipelotrichales) that either 
dropped significantly or disappeared (fell below the lower limit of detection 
[LLOD] of the quantitative sequencing method [49], [50]) in the upper GIT of 
non-coprophagic mice; 
2. “True small-intestine taxa” (e.g., Lactobacillales) that remained relatively stable 
in the upper GIT in non-coprophagic mice; 
3. Taxa that had lower absolute abundance in the cecum (e.g., Bacteroidales, 
Erysipelotrichales, Betaproteobacteriales) of non-coprophagic (compared with 
coprophagic) mice.  
Overall, the composition of the small-intestine microbiota of coprophagic mice was 
consistent with that previously reported in literature [46]. The upper-GIT microbiota in non-
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coprophagic mice was dominated by Lactobacilli (Fig. 3C), known to be a prominent 
microbial taxon in human small-intestine microbiota [14], [51], [52]. Importantly, the 
compositional analysis showed that the single TC-F mouse that had high microbial loads in 
its stomach and small intestine had a microbial composition in those segments of the GIT 
similar (i.e., dominated by Lactobacillales) to all other TC-F mice, and very distinct from all 
coprophagic mice (Fig. 3B,C). The PCA showed that the stomach and mid-small intestine of 
this mouse clustered with the stomach and mid-small intestine of all other TC-F mice (Fig. 
3A).  
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Fig. 2.3. Compositional and quantitative 16S rRNA gene amplicon sequencing of the 
gut microbiota. (A) Principal components analysis (PCA) of the log10-transformed and 
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standardized (mean = 0, S.D. = 1) absolute microbial abundance profiles in the stomach, 
mid-small intestine, and cecum. Loadings of the top contributing taxa are shown for each 
principal component. (B) Mean relative and absolute abundance profiles of microbiota in the 
mid-SI (order-level) for all experimental conditions. Functional tail cups (TC-F), mock tail 
cups (TC-M), housing on wire floors (WF), and controls housed in standard conditions 
(CTRL). N = 6 mice per experimental group, 4 of which were used for sequencing. (C) 
Absolute abundances of microbial taxa (order-level) compared between coprophagic and 
non-coprophagic mice along the mouse GIT. *Chloroplast and *Richettsiales (mitochondria) 
represent 16S rRNA gene DNA amplicons from food components of plant origin. Multiple 
comparisons were performed using the Kruskal–Wallis test. 
 
Changes in the small-intestine microbiota lead to differences in inferred microbial functional 
gene content 
We hypothesized that the quantitative and qualitative changes in the small-intestine 
microbiota induced by self-reinoculation may result in altered microbial function [53], [54] 
and an altered metabolite profile, either indirectly, as a result of functional changes in the 
microbiota, or directly via re-ingestion of fecal metabolites. To understand how such 
alterations to microbiota would impact microbial function in the small intestine, we next 
aimed to predict how the absolute abundances of functional microbial genes would be 
affected. We coupled the pipeline for microbial functional inference based on the 16S rRNA 
marker gene sequences (PICRUSt2) [55], [56] with our quantitative 16S rRNA gene 
amplicon sequencing approach [49], [50]. We focused our analysis on microbial functions 
that would be highly relevant to small-intestine physiology: microbial conversion of host-
derived bile acids and microbial modification of xenobiotics. 
We found that the inferred absolute abundances of a number of microbial gene orthologs 
implicated in enzymatic hydrolysis of conjugated bile acids (bile salt hydrolase, BSH [57]–
[59]) and xenobiotic conjugates (e.g., beta-glucuronidase, arylsulfatase [60], [61]) in the 
stomach and the small intestine of coprophagic mice were dramatically higher (in some cases 
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by several orders of magnitude) than in non-coprophagic mice (Fig. 4). This difference was 
not observed in the cecum. 
 
 
Fig. 2.4. Inference of microbial genes involved in bile-acid and xenobiotic conjugate 
modification along the GIT of coprophagic and non-coprophagic mice. Inferred absolute 
abundance of the microbial genes encoding (A) bile salt hydrolases (cholylglycine 
hydrolases), (B) beta-glucuronidases, and (C) arylsulfatases throughout the GIT (STM = 
stomach; SI2 = middle third of the small intestine (SI) roughly corresponding to the jejunum; 
CEC = cecum). KEGG orthology numbers are given in parentheses for each enzyme. In all 
plots, individual data points are overlaid onto box-and-whisker plots; whiskers extend from 
the quartiles (Q2 and Q3) to the last data point within 1.5 × interquartile range (IQR). 
Multiple comparisons were performed using the Kruskal–Wallis test; pairwise comparisons 
were performed using the Wilcoxon–Mann–Whitney test with FDR correction. N = 4 mice 
per group. 
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Changes in the small-intestine microbiota induced by self-reinoculation alter the bile acid 
profile 
Bile acids are a prominent class of host-derived compounds with multiple important 
physiological functions and effects on the host and its gut microbiota [62], [63]. These host-
derived molecules are highly amenable to microbial modification in both the small and large 
intestine [64]. The main microbial bile-acid modifications in the GIT include deconjugation, 
dehydrogenation, dehydroxilation, and epimerization [63]. Thus, we next performed 
quantitative bile acid profiling along the entire GIT to evaluate the effects of self-
reinoculation on bile acid composition. 
The small intestine is the segment of the GIT that harbors the highest levels of bile acids (up 
to 10 mM) and where they function in lipid emulsification and absorption [65]–[67]. Given 
these high concentrations of bile acid substrates, we specifically wished to analyze whether 
the differences we observed in small-intestine microbiota (Fig. 2, 3) between coprophagic 
and non-coprophagic mice would result in pronounced effects on microbial deconjugation 
of bile acids. We also wished to test whether any differences in bile-acid deconjugation were 
in agreement with the differences in the absolute BSH gene content we inferred (Fig. 4A) 
from the absolute microbial abundances (Fig. 3C). 
We first confirmed that in all four experimental groups, total bile acids levels (conjugated 
and unconjugated; primary and secondary) across all sections of the GIT were highest in the 
small intestine (Fig. 5A). We then compared the levels of conjugated and unconjugated (Fig. 
5B) as well as primary (host-synthesized) and secondary (microbe-modified) bile acids (Fig. 
S5) between coprophagic and non-coprophagic mice. 
Across all sections of the GIT and in bile, non-coprophagic mice (TC-F) had significantly 
lower levels of unconjugated bile acids compared with coprophagic mice (Fig. 5B). 
Consistent with the computational inference in Fig. 4A (performed on mid-SI samples only), 
in all three sections of the small intestine of non-coprophagic mice (TC-F), the levels of 
unconjugated bile acids were substantially lower than in coprophagic mice. Almost 100% of 
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the total bile acid pool remained in a conjugated form in the small intestine of non-
coprophagic mice. 
In all groups of coprophagic mice (TC-M, WF, and CTRL) the fraction of unconjugated bile 
acids gradually increased from the proximal to distal end of the small intestine. Gallbladder 
bile-acid profiling (Fig. 5B) confirmed that bile acids were secreted into the duodenum 
predominantly in the conjugated form in all coprophagic mice. This pattern is consistent with 
the hypothesis that the exposure of bile acids to microbial deconjugation activity increases 
as they transit down a small intestine with high microbial loads (Fig. 2A) [65]. 
In the large intestine, non-coprophagic (TC-F) mice carried a smaller fraction of 
unconjugated bile acids compared with all coprophagic experimental groups (Fig. 5B). 
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Fig. 2.5. Bile acid profiles in gallbladder bile and in lumenal contents along the entire 
GIT. (A) Total bile acid levels (conjugated and unconjugated; primary and secondary) and 
(B) the fraction of unconjugated bile acids in gallbladder bile and throughout the GIT (STM 
= stomach; SI1 = upper third of the small intestine (SI), SI2 = middle third or the SI, SI3 = 
lower third of the SI roughly corresponding to the duodenum, jejunum, and ileum 
respectively; CEC = cecum; COL = colon). In all plots, individual data points are overlaid 
onto box-and-whisker plots; whiskers extend from the quartiles (Q2 and Q3) to the last data 
point within 1.5 × interquartile range (IQR). Multiple comparisons were performed using the 
Kruskal–Wallis test; pairwise comparisons were performed using the Wilcoxon–Mann–
Whitney test with FDR correction. N = 6 mice per group. 
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Bile acid deconjugation in the small intestine of coprophagic mice was uniform for all glyco- 
and tauro-conjugates of all primary and secondary bile acids measured in our study, 
suggesting a broad-specificity BSH activity was provided by a complex fecal flora in the 
small intestine of those animals. 
In gallbladder bile and across all segments of the GIT from the stomach to the cecum, non-
coprophagic mice had a statistically significantly lower fraction of total secondary bile acids 
(conjugated and unconjugated) than coprophagic mice (Fig. S5). This change was uniform 
for the entire secondary bile acid pool of those analyzed. The only segment of the gut in 
which the difference in the fraction of secondary bile acids was not statistically significant 
between coprophagic and non-coprophagic mice was the colon. In fact, the differences in the 
fractions of total unconjugated and total secondary bile-acids between coprophagic and non-
coprophagic mice would have gone largely undetected had we only analyzed colonic 
contents or stool. These findings further highlight the importance of the comprehensive 
spatial interrogation of the complex crosstalk between the microbiota and bile acids in the 
gastrointestinal tract. 
 
Discussion 
In this study, we used modern tools for quantitative microbiota profiling and showed that 
when self-reinoculation with fecal flora is prevented, the mouse small intestine harbors 
dramatically lower densities of microbiota and an altered microbial profile. Consistent with 
published literature [27], [32], [39]–[43], we confirmed that single housing on wire floors 
failed to prevent mice from practicing coprophagy and that only functional tail cups reliably 
prevented the self-reinoculation with fecal flora. 
Despite its effectiveness, the tail cup approach has limitations. Tail cups in their current 
design may not be suitable for female rodents due to anatomical differences leading to urine 
entering and remaining inside the devices [68]. Animals need to be singly housed to prevent 
them from gnawing on each other’s tail cups and causing device failure or injury. The tail 
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cup approach may be hard to implement in younger and actively growing mice (e.g., before 
or around weaning). Some mice in our study developed self-inflicted skin lesions from over-
grooming at the location where the tail cups come in contact with the body at the animal’s 
hind end. Thus, we concluded that the approach in its current implementation is limited to 2-
3 weeks in adult animals. 
Our device design reduced the risk of tail injury and necrosis described in previous works 
[44] and allows for emptying the cups only once every 24 hours to reduce handling stress. 
Because host stress can affect the microbiota [69] and other physiological parameters, we 
included a mock tail-cup group. Both TC-F and TC-M mice demonstrated a similar degree 
of weight loss (Fig. S3A) when compared with the WF and CTRL mice despite similar food 
intake rates across all four groups (Fig. S3B). Mice fitted with mock tail cups (TC-M) had 
microbial patterns and bile acids profiles similar to control mice (CTRL), thus the effects we 
observed in non-coprophagic mice are not attributable to stress. 
We believe that the tail cup approach is implementable in gnotobiotic settings (e.g., flexible 
film isolators and individually ventilated cages), which can aid studies that involve 
association of mice with defined microbial communities or with human-derived microbiota. 
 
The non-coprophagic mouse model may be more relevant to humans 
Using quantitative microbiota profiling, our study demonstrated that preventing self-
reinoculation dramatically reduced the total levels of several prominent taxonomical groups 
of obligate anaerobes (e.g., Clostridiales, Bacteroidales, Erysipelotrichale) in the upper 
gastrointestinal microbiota of conventional mice. Despite these differences in taxa, levels of 
Lactobacillales in the small intestine and cecum, but not in the stomach, remained similar 
between coprophagic and non-coprophagic animals (Fig. 3C). The physiological 
significance of the maintained persistent population of Lactobacillales in the upper 
gastrointestinal tract (e.g., stomach or small intestine) and their overall consistent presence 
along the entire GIT [25], [70] for the host is not fully understood. However, Lactobacilli 
34 
 
colonization in the stomach and small intestine has been shown to promote resistance to 
colonization by pathogens (reviewed in [71], [72]). 
Compared with conventional (coprophagic) mice, the non-coprophagic mice displayed 
features of the small-intestine microbiota and bile acid profiles that are more similar to the 
patterns seen in the small intestine of humans: orders of magnitude lower microbiota density, 
reduced abundance of obligate anaerobic flora and dominance of Lactobacillales, and a 
higher ratio of conjugated bile acids. These findings highlight the need to understand and 
control self-reinoculation in mouse models used to answer questions relevant to host-
microbiota interactions in human health. 
 
Self-reinoculation and microbial ecology in the mouse GIT 
We observed that within the approximately two-week timeframe of our study, the 
taxonomical diversity of the mouse large-intestine microbiome was stable in the absence of 
persistent microbial self-reinoculation: all taxonomical groups at the order level observed in 
the cecum of coprophagic mice were present in the cecum of non-coprophagic mice, and 
vice versa. 
The trending changes in the absolute abundances of several taxa in the large intestine of non-
coprophagic mice may be the result of eliminated self-reinoculation and/or the consequence 
of the altered profile of bile acids entering the cecum from the small intestine. It has been 
previously suggested that the degree of bile acid deconjugation may alter the microbiota 
profile [57]. 
Stability of complex microbiomes in response to perturbations with and without continuous 
species reintroduction is an important subject of research in microbial ecology [73], [74]. 
Eliminating fecal ingestion provides a way to study stability and recovery of the mouse gut 
microbiota (e.g., in response to dietary change or antibiotic exposure [75]) in a way more 
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relevant to modern humans. Thus, non-coprophagic mouse model can significantly aid such 
research. 
Self-reinoculation with fecal flora leads to altered bile acid profiles in the GIT 
We demonstrated that changes to small-intestine microbiota density and composition had 
pronounced effects on microbial function resulting in increased bile acid deconjugation in 
that segment of the GIT. 
Bile acid deconjugation is a microbiota-mediated process that in healthy humans is 
conventionally believed to take place in the distal small intestine (ileum) and in the large 
intestine [76] such that sufficient lipid emulsification (with conjugated bile acids) and 
absorption can take place in the small intestine by the time digesta reaches the ileum [77]. 
As a result of the much higher bile acid concentrations in the small intestine compared with 
the large intestine, altered deconjugation of bile acids in the small intestine may have more 
wide-ranging effects on the entire enterohepatic system. Our data indicate that bile acid 
deconjugation can take place in any segment of the small intestine of conventional healthy 
mice as a function of the microbial density and composition (Fig. 2A, 3, 5B), which is 
consistent with previous findings in animal models and in humans with small-intestinal 
microbial overgrowth (SIBO) [78]–[82]. 
Strikingly, the very low degree of bile acid deconjugation in the small intestine of non-
coprophagic mice in our study resembles profiles seen in germ-free animals [83]–[85], 
gnotobiotic animals colonized only with microbes incapable of deconjugating bile acids 
[86]–[89], and antibiotic-treated animals [90]–[92]. Our observations suggest a mechanistic 
link between the small-intestine microbiota density and composition and the bile acid 
modification in this segment of the GIT. The small intestine of healthy human subjects is 
believed to harbor bile acids predominantly in the conjugated form [93], which further 
substantiates that (compared with coprophagic mice) the small intestine of non-coprophagic 
mice is more similar to the small intestine of a healthy human. 
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Although microbiota density and composition in the large intestine of coprophagic and non-
coprophagic mice were largely similar, non-coprophagic mice had a higher fraction of bile 
acids that remained in the conjugated form in the large intestine (Fig. 4B), likely as a result 
of the bile acids entering the large intestine from the ileum predominantly in a conjugated 
form. Additionally, across all study groups, the total concentrations of bile acids in the small 
intestine were ~10-fold greater than in the large intestine. We therefore infer that in 
coprophagic mice a greater absolute amount of bile acids underwent deconjugation in the 
small intestine than in the large intestine, i.e., in coprophagic mice, the small intestine 
contaminated with high loads of fecal flora was the primary site of bile acid deconjugation. 
Regulation of bile acid deconjugation activity in the gut is considered a potential health-
promoting modality in a number of contexts, including lowering blood cholesterol levels 
(reviewed in [94]–[96]). BSH-active probiotics can be a promising delivery vehicle for 
promoting increased bile acid deconjugation in the gut. Our study emphasizes the importance 
of controlling for self-reinoculation when using mice to study the effects of BSH-active 
microbial strains or probiotics [59], [97]–[102] (especially those with high selectivity for 
particular bile acid conjugates [58], [86], [89]) because conventional (coprophagic) mice 
already have pronounced BSH activity in their small intestines. A non-coprophagic mouse 
may be a better animal model in such studies. 
Our findings also have implications for the use of conventional (coprophagic) mice in diet 
studies. Deconjugated bile acids are less effective than conjugated at lipid emulsification and 
fat micelle formation [78], [103]. Increased bile acid deconjugation in the small intestine of 
animals and humans can lead to lipid malabsorption and fat-soluble vitamin deficiency and 
in extreme scenarios even to steatorrhea [81], [104]. Previous research has shown that the 
small-intestine microbiota plays an important role in mediating the effect of high fat diets on 
the host [105]; our results suggest that future studies of the microbiota-mediated effects of 
high fat diets need to consider increased microbial bile acid deconjugation in the mouse 
intestine due to self-reinoculation with fecal flora. 
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Bile acid deconjugation is considered to be obligatory [88], [106], [107] before the secondary 
bile acid metabolism (believed to be predominantly occurring in the large intestine [76]) can 
take place. These reactions in many cases are carried out by different members of the 
microbiota. Thus, the reduction of the deconjugation activity in the small intestine of non-
coprophagic mice and consequently lower availability of free primary bile acids to further 
microbial modification can explain the decrease in the secondary bile acid fraction 
(percentage of all bile acids) in the bile acid pool across the GIT and gallbladder bile of non-
coprophagic mice in our study. A similar but more pronounced trend has been observed in 
rabbits [108]. Reduced oral intake and recycling of fecal secondary bile acids as a result of 
eliminating coprophagy may also be a contributing factor to the lower fraction of secondary 
bile acids in the total bile acid pool in the enterohepatic circulation in these animals. 
Total bile acid levels in the stomach were similar in coprophagic and non-coprophagic mice 
(and agree with literature [108], [109]), however bile acid profiles (including the fraction of 
total unconjugated and total secondary bile acids) were substantially different. Surprisingly, 
in all coprophagic mice the fraction of unconjugated bile acids in the stomach appeared to be 
intermediate between the profiles in the small intestine and in the large intestine (Fig. 5B), 
suggesting that the bile acids in the stomach of coprophagic mice could be accumulating 
from bile acids re-ingested in feces and bile acids refluxed from the duodenum. This pattern 
was not observed in non-coprophagic mice, suggesting that coprophagy may alter the bile 
acid profile in the upper GIT both directly (via re-ingestion of fecal metabolites) and 
indirectly (via altered microbiota function). 
Inferences about microbial function in bile acid and drug modification 
Our quantitative functional gene inference analysis predicted differential absolute abundance 
of the BSH orthologs between the small intestine of coprophagic and non-coprophagic mice 
(Fig. 4A). This approach has limitations associated with incomplete gene annotations, limited 
ability to infer metagenomes from the marker gene sequences when multiple microbial 
strains with similar 16S rRNA gene sequences exist [55], [56], difficulty to predict the exact 
gene expression and enzyme activity and specificity. To test our prediction about the BSH 
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we employed the targeted bile acid metabolomic analysis of mouse gastrointestinal samples 
and observed the differences in the small-intestine bile acid deconjugation between 
coprophagic and non-coprophagic mice (Fig. 5B) that were in agreement with the differences 
in the inferred BSH gene abundances in the small intestine of those two types of animals 
(Fig. 4A). 
We next explored the effects of self-reinoculation on the absolute abundance of microbial 
gene orthologs implicated in xenobiotic modification [110] in the small intestine as 
microbiota-dependent drug modification and toxicity in the small intestine have been 
previously observed in rodents [111]–[121]. Many drugs administered to humans and mice 
both via enteral and parenteral routes after reaching the systemic circulation are transformed 
by the liver into conjugates (e.g., glucuronic acid-, sulphate-, or glutathione-conjugates) and 
excreted with bile into the GIT lumen. Such transformations are believed to reduce the small-
intestine reabsorption of xenobiotics and promote their excretion from the body with stool. 
Alterations in the small-intestine microbiota may also lead to increased hydrolysis of such 
conjugates by microbial enzymes and promote the local toxicity of the drug and enable its 
re-uptake from the small intestine (i.e., undergo enterohepatic circulation) [21], [119], 
resulting in an increase in the xenobiotic flux through the liver [122], [123] and to an overall 
microbiota-dependent change in drug pharmacokinetics. 
As with the inferred differential BSH absolute abundances (correlating activity of which we 
confirmed with the bile acid deconjugation measurements), our analysis predicted 
differences in the absolute abundance (Fig. 4B, C) of the microbial gene orthologs 
responsible for drug conjugate hydrolysis (e.g., beta-glucuronidases, sulfohydrolases) 
between the small intestine of coprophagic and non-coprophagic mice. If this prediction is 
further experimentally confirmed, it would imply that self-reinoculation must be controlled 
for or taken into account when investigating the drug pharmacology in mice. 
Relevance of self-reinoculation in probiotics research 
Many studies on probiotics and their effects on host animal physiology rely on repeated oral 
administration of live probiotic microorganisms to rodents. Our study suggests that self-
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reinoculation with live fecal flora in laboratory mice could both interfere with and introduce 
inconsistencies in live probiotic administration regimens. As has been stated earlier, 
particular attention should be given to self-reinoculation and its effects on the small-intestine 
bile acid profile in studies aiming to evaluate the health effects of probiotics and other 
therapeutic modalities [59], [94]–[102] targeting bile acid deconjugation and metabolism. 
Relevance of mouse models in human microbiota research 
The role of mouse models in human microbiota research remains a subject of a debate [24], 
[25], [124]. At the same time, the field is recognizing the importance of reproducibility in 
gut microbiota research that uses mouse models [69], [124]. Several recent studies have 
highlighted the variability in lab-mouse microbiota related to animal strains and sources of 
origin [47], [125]–[129]. Others have attempted to catalog “normal” or “core” gut 
microbiome [130], [131] and its spatial organization [46], [47] and function [132] in 
laboratory and wild mice. Recently, the small-intestine microbiome has become the focus of 
studies conducted in mice in the context of host physiology [105] and disease [15], [133]. 
Yet, little attention has been given to the impact of self-reinoculation on the gut microbiota 
spatial structure and function or to how study outcomes might be affected by controlling (or 
not controlling) for this experimental parameter in mouse models. 
Self-reinoculation in rodents may affect not only their native microbiota, but also individual 
microbial colonizers [35] (e.g., in gnotobiotic animals) and complex xenomicrobiota (e.g., in 
human microbiota-associated (HMA) mice). HMA mice have emerged as an important 
research model for dissecting the mechanistic connection between the gut microbiota and the 
host phenotype in health and disease, even though the field acknowledges its  limitations 
[134], [135]. Compositional differences between the small-intestine and large-intestine 
microbiomes in primates and humans [23], [51], [52] appear to be more substantial than those 
reported for laboratory mice [46], [132]. Our study emphasizes that the compositional 
similarity between small- and large-intestine microbiota in conventional laboratory mice can 
be a result of self-reinoculation with fecal flora. Thus, the effects of self-reinoculation on the 
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spatial organization and function of human microbiota in HMA mice warrant future 
exploration. 
In conclusion, this study uses modern tools to demonstrate the importance of self-
reinoculation in the context of microbial ecology and function within the mammalian 
gastrointestinal system. Our work highlights the importance of recognizing and properly 
controlling for self-reinoculation when murine studies analyzing small-intestine microbiota 
and its function intend to draw parallels with human physiology and pathophysiology. 
Additionally, spatial interrogation of the gut microbiota and its function in mouse models is 
important because even dramatic changes in the small-intestine microbiome profile, 
function, and metabolome may be overlooked if only large-intestine and stool samples are 
analyzed.  
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METHODS 
Experimental animals 
All animal handling and procedures were performed in accordance with the California 
Institute of Technology (Caltech) Institutional Animal Care and Use Committee (IACUC). 
C57BL/6J male specific-pathogen-free (SPF) mice were obtained at the age of 7-8 weeks 
from Jackson Laboratory (Sacramento, CA, USA) and housed four mice per cage. Two 
cohorts of animals were used: the first cohort was allowed to acclimate in the Caltech animal 
facility for 2 months and mice were 4 months old at the start of the study; the second cohort 
acclimated for 6 months and mice were 8 months old at the start of the study. 
All animals were maintained on chow diet (PicoLab Rodent Diet 20 5053, LabDiet, St. 
Louis, MO, USA) and autoclaved water ad lib and subjected to a daily 13:11 light:dark cycle 
during acclimation and throughout the entire study. Mice were given measured amounts of 
food, and food intake during the experiment was measured by weighing the food during 
weekly cage changes and at the end time point for each animal. Body weight was measured 
at the start of the experiment, during weekly cage changes, and at the end time point. 
 
Animal housing conditions 
During the experiment, all mice were singly housed in autoclaved cages (Super Mouse 750, 
Lab Products, Seaford, DE, USA). The mice in the control (CTRL), mock tail cup (TC-M) 
and functional tail cup (TC-F) treatments were housed on heat-treated hardwood chip 
bedding (Aspen Chip Bedding, Northeastern Products, Warrensburg, NY, USA) and 
provided with tissue paper (Kleenex, Kimberly-Clark, Irving, TX, USA) nesting material. 
The mice in the wire-floor (WF) treatment were housed on raised wire floors with a mesh 
size of 3 × 3 per square inch (#75016, Lab Products) and provided with floorless paper huts 
(#91291, Shepherd Specialty Papers, Watertown, TN, USA). A thin layer of woodchip 
bedding was added under the wire floors to absorb liquid waste from the animals (Fig. S1D). 
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Tail cup design and mounting 
We designed the tail cups based on published literature [41], [136]–[138], including the 
locking mechanism [41]. Each cup was locked in place around the hind end of animals by 
anchoring to a tail sleeve designed with a perpendicular groove. Such tail sleeves allow for 
the cup to be held snugly against the animal so that the total weight of the tail cup is 
distributed along a large surface area of the tail skin, which minimizes complications. When 
mounted, the tail cups can freely rotate along the longitudinal axis, which ensures the locking 
mechanism does not strangulate the tail. 
We hand-made the tail cups from 20 mL syringes (#4200.000V0 Norm-Ject 20 mL Luer-
Lock, Henke-Sass Wolf GmbH, Tuttlingen, Germany) as depicted on Fig. S1A-C. Multiple 
perforations were designed to accelerate desiccation of the captured fecal pellets. Lateral slits 
allowed for increasing the diameter of the locking edge; pressing on the slits with two fingers 
allowed tail cups to be quickly unfastened from tail sleeves. Mock tail cups were modified 
with wide gaps in the walls to allow the fecal pellets to fall out of the cup. 
To prevent mice from gnawing on the plastic parts of the tail cups (which could create a 
jagged edge and lead to a subsequent injury), they were reinforced with metal flared rings 
made from stainless steel grommets (#72890, SS-4, C.S. Osborne, Harrison, NJ, USA) that 
were modified to reduce their size and weight. Metal rings were attached to tail cups using 4 
mm-wide rubber rings cut from latex tubing (Amber Latex Rubber Tubing #62996-688, 1/2” 
ID, 3/4” OD; VWR, Radnor, PA, USA). 
Tail sleeves were made from high-purity silicone tubing (HelixMark 60-411-51, 1/8" ID, 
1/4" OD; Helix Medical, Carpinteria, CA, USA). The tubing was split longitudinally and a 
2.0 mm wide strip of the wall was removed to accommodate for variable tail diameters 
among animals and along the tail length, to prevent uneven tail compression, and to facilitate 
uniform application of the tissue adhesive. The perpendicular tail-cup mounting groove was 
made using a rotary tool (Craftsman #572.610530, Stanley Black & Decker, New Britain, 
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CT, USA) equipped with a cutting disc (RD1, Perma-Grit Tools, Lincolnshire, UK). Each 
tail cup and sleeve together weighed approximately 4.12 g empty. 
Before mounting the tail cups, animals were anesthetized with 10 min isoflurane and placed 
on a heating pad to maintain body temperature. Sleeves were de-greased on the inside using 
70% ethanol and a veterinary tissue adhesive (GLUture Topical Adhesive #32046, Abbott 
Laboratories, Lake Bluff, IL, USA) was applied to the tail base. The adhesive was allowed 
to cure for 5 min and then tail cups were mounted. Mice were returned back to their cages 
and allowed to recover from the anesthesia and ambulate. 
Tail cups were emptied of fecal pellets daily at 08:00 AM. Mice were prompted to enter a 
restrainer [139] made from a black polypropylene 50 mL conical tube (TB5000 LiteSafe, 
Cole-Parmer, Vernon Hills, IL, USA) and the tail cups were unclipped and quickly emptied. 
Any residue on the tail cup was cleaned using a paper towel and Rescue solution (Virox 
Technologies, Oakville, ON, Canada) prior to the cups being remounted. Animals fitted with 
the mock tail cups were subjected to the identical procedure to match the handling conditions. 
Tail cups were mounted in animals for a duration of between 12 and 20 days. All TC-F 
animals were time-matched with TC-M animals, (i.e., each animal from the TC-F group had 
a time-matched animal from the TC-M group handled and euthanized at the same time). 
 
Sample collection and treatment 
All mice were euthanized as approved by the Caltech IACUC in accordance with the 
American Veterinary Medical Association Guidelines on Euthanasia [140]. Mice were 
euthanized while under isoflurane anesthesia (delivered via a calibrated gas vaporizer in an 
induction chamber followed by maintenance on a nose cone) via cardiac puncture followed 
by cervical dislocation. Blood was collected using a 1 mL syringe (#309659, Becton 
Dickinson) and 21G × 1” needle (#26414, EXELINT International, Redondo Beach, CA, 
USA). 
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Blood was immediately placed into K2EDTA plasma separation tubes (MiniCollect 450480, 
Greiner Bio-One GmbH, Kremsmünster, Austria), gently mixed, and stored on ice for up 1 
h prior to centrifugation. Bile and urine were collected directly from the gall and urinary 
bladders respectively using a 1-mL syringe (#4010.200V0 Norm-Ject 1 mL Tuberculin Luer, 
Henke-Sass Wolf GmbH) and 27G × 1/2” needle (#26400, EXELINT International) and 
stored on ice. 
Fecal samples were collected if present at the time of euthanasia. The entire gastrointestinal 
tract was excised from the gastro-esophageal junction to the anal sphincter and stored on ice 
during processing. 
 
Plasma separation: 
Blood samples were centrifuged in the plasma separation tubes at 2000 RCF for 5 min at 4 
°C. Plasma was separated and stored at -80 °C. 
 
Processing of GIT contents  
To prepare samples for the main experimental analyses (Fig. 2-4), each mouse GIT was split 
into stomach, three equal-length thirds of the small intestine, cecum, and colon. Contents 
from each segment of the GIT were flushed out using 2-5 mL of cold (4 °C) sterile autoclaved 
saline solution (0.9% NaCl (#S5886, Sigma-Aldrich) in ultrapure water (Milli-Q, 
MilliporeSigma, Burlington, MA, USA)) followed by very gentle squeezing with tweezers 
to avoid mucosal damage. All samples were stored on ice during processing. 
An aliquot of each sample diluted in saline was concentrated by centrifugation at 25000 RCF 
for 10 min at 4*C. The supernatant was removed and the pellet was reconstituted in 9 
volumes of 1× DNA/RNA Shield (DRS) solution (R1100-250, Zymo Research, Irvine, CA, 
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USA), mixed by vortexing and stored at -80 °C for future DNA extraction. Separate aliquots 
of each sample were stored at -80 °C for the metabolomic (bile acid) analysis. 
Preparation of GIT contents for the MPN-based microbial quantification and 16S rRNA gene 
amplicon sequencing (pilot study; Fig. S4B) was the same as above, but conducted inside a 
vinyl anaerobic chamber (Coy Laboratory Products, Grass Lake, MI, USA) in an atmosphere 
of 5% hydrogen, 10% carbon dioxide, and 85% nitrogen. All samples were maintained on 
ice and immediately processed for the culture-based assay. 
Preparation of GIT mucosa 
After flushing its contents, each segment of the GIT was gently rinsed in sterile cold (~4 °C) 
saline, cut longitudinally, and placed flat on a glass slide. The mucosa was scraped from the 
tissue gently using a second clean glass slide. Glass slides (VistaVision #16004-422, VWR) 
were sterilized by dry heat sterilization at 200 °C for at least 2 h. Mucosal scrapings were 
collected and combined with 9 volumes of DRS solution, mixed by vortexing, and stored at 
-80 °C in preparation for DNA and RNA extraction. 
 
Most probable number (MPN) assay 
For the pilot study (Fig. S4A), the MPN assays (adapted from [141]–[145]) were performed 
on each GIT section (stomach, three sub-sections of the small intestine, cecum, and colon) 
from five mice fitted with functional tail cups and five control mice. The growth medium 
was brain-heart infusion broth (Bacto BHI, #237500, Becton Dickinson, Franklin Lakes, NJ, 
USA), prepared in ultrapure water (Milli-Q), sterilized by autoclaving, allowed to cool to 
room temperature, and supplemented with 1.0 mg/L vitamin K1 (#L10575, Alfa Aesar, 
Haverhill, MA, USA), 5 mg/L hematin (#H3281, Sigma-Aldrich St. Louis, MO, USA), and 
0.25 g/L L-cysteine (#168149, Sigma-Aldrich). The medium was allowed to equilibrate 
inside the anaerobic chamber for at least 24 hours before use. 
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MPN assays were performed in clear, sterile, non-treated polystyrene 384-well plates (Nunc 
265202, Thermo Fisher Scientific, Waltham, MA, USA). Two series of eight consecutive 
10-fold serial dilutions were prepared from each sample in sterile autoclaved saline solution 
(equilibrated inside the anaerobic chamber for at least 24 h) on clear sterile non-treated 
polystyrene 96-well plates (Corning Costar 3370, Corning, NY, USA). We injected 10 µL 
of each serial dilution from each series into four (eight total per dilution) culture-medium 
replicates (wells) filled with 90 µL of the BHI-S broth medium. 
Plates were sealed with a breathable membrane (Breath-Easy BEM-1, Diversified Biotech) 
and incubated for 5 d at 37.0 °C inside the anaerobic chamber. The plates were lidless for the 
first 24 h to facilitate uniform gas equilibration, then from 24 h to the end of the incubation 
period (120 h), a plastic lid was kept over the plates. 
At the end of the incubation, the plates were scanned using a flatbed scanner (HP ScanJet 
8250, Hewlett-Packard, Palo Alto, CA, USA) in the reflective mode with black background 
at 300 dpi resolution. The positive wells (replicates) were called by visually observing each 
acquired high-resolution image. The MPN for each sample was calculated using Microsoft 
Excel with the “Calc_MPN” macro [146]. 
 
DNA extraction 
DNA was extracted from thawed GIT contents and mucosal sample aliquots preserved in 
DRS solution with the ZymoBIOMICS DNA Miniprep Kit (D4300, Zymo Research) 
according to the manufacturer’s instructions. Samples were homogenized on a bead-beater 
(MiniBeadBeater-16, Model 607, Bio Spec Products, Bartlesville, OK, USA) for 5 min at 
the default speed of 3450 RPM. Quantitative recovery of DNA across multiple orders of 
microbial loads in the samples was previously verified in [49]. 
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DNA yield and purity in the extracts was evaluated via light absorbance (NanoDrop 2000c, 
Thermo Fisher Scientific) and via a fluorometric assay (Qubit dsDNA HS Assay Kit Q32854, 
Thermo Fisher Scientific) on a fluorometer (Invitrogen Qubit 3, Thermo Fisher Scientific). 
 
Quantitative PCR (qPCR) for 16S rRNA gene DNA copy enumeration 
The qPCR reactions were set up in triplicates for each DNA sample. A single replicate 
reaction volume of 15 µL contained 1.5 µL of the DNA extracts combined with the qPCR 
master mix (SsoFast EvaGreen Supermix, #172-5200, Bio-Rad Laboratories, Hercules, CA, 
USA), forward and reverse primers (synthesized by Integrated DNA Technologies, San 
Diego, CA, USA; Table S1) at a final concentration of 500 nM, and ultrapure water 
(Invitrogen UltraPure DNase/RNase-Free Distilled Water 10977-015, Thermo Fisher 
Scientific). Reactions were set up in white 96-well PCR plates (#HSP9655, Bio-Rad 
Laboratories) sealed with a PCR tape (#MSB1001, Bio-Rad Laboratories). 
The standard curve was built for each qPCR run based on the included series of 10-fold 
dilutions of the “standard” SPF mouse fecal DNA extract (with the quantified absolute 
concentration of 16S rRNA gene copies using digital PCR). 
Amplification was performed with real-time fluorescence measurements (CFX96 Real-Time 
PCR Detection System, Bio-Rad Laboratories). Thermocycling conditions were used 
according to Table S2. The qPCR data files were analyzed using Bio-Rad CFX Manager 3.1 
(#1845000, Bio-Rad Laboratories) and the Cq data were exported to Microsoft Excel for 
further processing. 
 
Digital PCR (ddPCR) for absolute 16S rRNA gene DNA copy enumeration 
Droplet digital PCR (ddPCR) reactions were set up according to [49]. Single replicate 
reaction volume of 20 µL contained 2.0 µL of the DNA extracts combined with the ddPCR 
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master mix (QX200 ddPCR EvaGreen Supermix, #1864033, Bio-Rad Laboratories), forward 
and reverse primers (synthesized by Integrated DNA Technologies; Table S1) at final 
concentration of 500 nM each, and ultrapure water (Thermo Fisher Scientific). 
Droplets were generated using DG8 cartriges (#1864008, Bio-Rad Laboratories), droplet 
generation oil (#1864006, Bio-Rad Laboratories), and DG8 gaskets (#1863009, Bio-Rad 
Laboratories) on a QX200 droplet generator (#1864002, Bio-Rad Laboratories) and analyzed 
using a QX200 Droplet Digital PCR System (#1864001, Bio-Rad Laboratories) using droplet 
reader oil (#1863004, Bio-Rad Laboratories). The ddPCR data files were analyzed using 
QuantaSoft Software (#1864011, Bio-Rad Laboratories) and the raw data were exported to 
Microsoft Excel for further processing. 
Thermocycling conditions were used according to [49] and Table S3. Amplification was 
performed in PCR plates (#0030133374, Eppendorf, Hauppauge, NY, USA) sealed with 
pierceable heat seals (#1814040, Bio-Rad Laboratories) using PCR plate sealer (PX1, 
#1814000, Bio-Rad Laboratories) on a 96-deep well thermocycler (C1000 Touch, # 
1841100), Bio-Rad Laboratories). 
 
16S rRNA gene DNA amplicon barcoding for next generation sequencing (NGS) 
PCR reactions was set up according to [49], in triplicates for each DNA sample. Single-
replicate reaction volumes of 30 µL contained 3 µL of the DNA extracts combined with the 
PCR master mix (5PRIME HotMasterMix, #2200400, Quantabio, Beverly, MA, USA), 
DNA intercalating dye (EvaGreen, #31000, Biotium, Fremont, CA, USA) at the suggested 
by the manufacturer concentration (×1), barcoded forward and reverse primers (synthesized 
by Integrated DNA Technologies; Table S1) at final concentration of 500 nM each, and 
ultrapure water (Thermo Fisher Scientific). 
Reactions were set up in 0.2 mL white PCR tubes (#TLS0851) with flat optical caps 
(#TCS0803, Bio-Rad Laboratories). 
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Thermocycling conditions were used according to [49] and Table S4. Amplification was 
performed with real-time fluorescence measurements (CFX96 Real-Time PCR Detection 
System, Bio-Rad Laboratories) and samples were amplified for a variable number of cycles 
until the mid-exponential (logarithmic) phase to maximize the amplicon yield and minimize 
artifacts related to over-amplification [2]. 
 
Digital PCR (ddPCR) for Illumina library quantification 
Single replicate reaction volume of 20 uL contained 2.0 uL of the diluted amplicon sample 
ligated with the Illumina adapters, 10 uL of ddPCR master mix (QX200 ddPCR EvaGreen 
Supermix, #186-4033, Bio-Rad Laboratories), forward and reverse primers (synthesized by 
Integrated DNA Technologies; Table S1) targeting the Illumina P5 and P7 adapters 
respectively at the final concentration of 125 nM each, and ultrapure water (Invitrogen). 
Thermocycling conditions were used according to Table S5. PCR amplification and droplet 
analysis were performed as above. 
 
Barcoded sample quantification, pooling, library purification and quality control 
Triplicates of each barcoded amplicon sample were combined. Each samples was diluted × 
105-107-fold and the molar concentration of barcoded amplicons was quantified using a 
home-brew ddPCR library quantification assay and KAPA SYBR FAST Universal qPCR 
Library Quantification Kit (#KK4824, Kapa Biosystems, Wilmington, MA, USA) according 
to the manufacturer’s instructions (the qPCR reaction was set up same as above). 
Barcoded samples were pooled in equimolar amounts. Pooled library was purified using 
Agencourt AMPure XP beads (#A63880, Beckman Coulter, Brea, CA, USA) according to 
the manufacturer’s instructions and eluted with ultrapure water (Invitrogen). 
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The purified library was confirmed to have the 260 nm to 280 nm light absorbance ratio of 
>1.8 using a NanoDrop 2000c spectrophotometer (Thermo Fisher Scientific). The average 
amplicon size of approximately ~400 bp was confirmed with a High Sensitivity D1000 
ScreenTape System (##5067-5584 and 5067-5585, Agilent Technologies, Santa Clara, CA, 
USA) using a 2200 TapeStation instrument (Agilent Technologies) and the Agilent 2200 
TapeStation Software A02.01. (Agilent Technologies). 
The molar concentration of the pooled library was measured using the ddPCR and KAPA 
qPCR assays and the library was submitted for next generation sequencing (NGS) with the 
sequencing primers described in Table S1. 
 
Next generation sequencing 
The library was sequenced on a MiSeq instrument (Illumina, San Diego, CA, USA) in a 300-
base paired-end mode using a MiSeq Reagent Kit v3 (#MS-102-3003, Illumina). PhiX 
control spike‐in was added at 15%. 
 
PCR primer oligonucleotides (Table S1) 
Same universal microbial 16S rRNA gene V4 primers (modified from [1], [3] and validated 
in [49], [50]) targeting the V4 region of the 16S rRNA gene from the 519 to 806 positions 
were used for 16S rRNA gene DNA copy quantification and multiplexed microbial 
community profiling based on 16S rRNA gene amplicon sequencing. Reverse barcoded 
primers for 16S rRNA gene DNA amplicon barcoding were according to [3]. 
Primers targeting the P5 and P7 Illumina adapters for barcoded amplicon and pooled library 
quantification using the ddPCR assay were according to [1], [3], [147]–[149]. 
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Sequencing read processing 
Demultiplexed 2 × 300 reads were processed using the Qiime2-2019.01 pipeline [150]. 
DADA2 plugin [151] was used to filter (forward trimming – 5, forward truncation – 230, 
reverse trimming – 5, reverse truncation – 160), denoise, merge the paired-end sequences, 
and remove the chimeras. Taxonomic sequence (amplicon sequence variant, ASV) 
classification was performed using the classifier (available for download from [152]) trained 
[153] on the V4 515-806 bp regions of 16S rRNA gene sequences from the Silva rRNA 
reference database, release 132 [4] (available for download from [154]). 
Functional gene inference analysis with the PICRUSt2 [55], [56] was performed on the 
ASVs within the Qiime2 environment. Absolute and relative abundances of ASVs were 
normalized using the inferred 16S rRNA gene DNA copy counts. Obtained predicted 
metagenome data were used to calculate the normalized relative and absolute abundances of 
the gene orthologs of interest using Python tools (described below). 
 
Sequencing data processing 
Data handling, calculations, and statistical analyses were performed using Microsoft Excel 
with the Real Statistics Resource Pack [155], and the Python packages NumPy [156], Pandas 
[157], SciPy [158], Statsmodels [159]. Plotting was performed with Matplotlib [160] and 
Seaborn [161]. All Python packages were run using IPython [162] within Jupyter notebooks 
[163] distributed with the Anaconda environment [164]. 
Frequency data for the 16S rRNA gene ASVs assigned to taxa in each sample were converted 
to relative abundances for each sample. Relative abundances then were converted to absolute 
abundances using the corresponding values of total 16S rRNA gene DNA loads obtained 
from the qPCR and ddPCR assays for each sample. 
Absolute abundance data were then collapsed to the genus (Fig. 3A) or order (Fig. 3B,C) 
taxonomical levels using a custom made Python function (confirmed to yield identical results 
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to the “collapse” method of the Qiime2 “Taxa” plugin [150]). We defined contaminating 
taxa (from sample handling during collection or from the DNA extraction kit or PCR 
reagents) using two methods: taxa that were not present in at least 1 out of 16 cecum contents 
samples (4 mice out of 6 from each group × 4 groups), and taxa identified with a frequency-
based contaminant identification [165] implemented by us in Python. Data for chloroplasts 
and mitochondria of plant origin (likely from the chow diet) were kept in the dataset for Fig. 
3A and 3C and removed for Fig. 3B. Mean absolute abundances of taxa for each group were 
calculated, converted to relative abundances, and plotted in Fig. 3B. 
Principle component analysis (PCA) of the relative abundance data (Fig. S4B) was 
performed on centered log-ratio (CLR)-transformed [166], [167] (after a pseudocount equal 
to the minimal non-zero sequence count in the dataset was added to all zero values) genus-
level relative abundance data using the Python Scikit-learn package [168]. 
PCA of the absolute abundance data (Fig. 3A) was performed on log10-transformed and 
centered-standardized (converted to normally-distributed data with mean = 0 and standard 
deviation = 1) [169] genus-level absolute abundance data using the Python Scikit-learn 
package [168]. 
 
Bile acid analysis 
Reagents: 
TαMCA, TβMCA, TωMCA, THCA, αMCA, βMCA, ωMCA, HCA, HDCA, MCA, 
GCDCA, GDCA, and GCA (Table S6) were obtained from Steraloids (Newport, Rhode 
Island, USA). 
TCA, CA, DCA, TCDCA, TDCA, TUDCA, TLCA, CDCA, UDCA, LCA, D4-TCA, D4-
DCA, D4-CA, D4-TDCA, D4-GLCA, D4-GUDCA, D4-GCDCA, D4-GCA, and D4-GDCA 
(Table S6) were obtained from Isosciences (Ambler, PA, USA). 
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LC/MS grade acetonitrile (#A955-500), water (#W6500), and formic acid (#A117-50) were 
obtained from Thermo Fisher Scientific. 
 
Sample preparation 
To overcome sample buffering (pH issues), samples were extracted (using a protocol adapted 
and modified from [87]–[89]) in 9 volumes of ethanol with 0.5% formic acid and nine 
different heavy isotope (D4) internal standards at 5 µM. D4 internal standards were 
taurocholic acid (TCA), cholic acid (CA), deoxycholic acid (DCA), taurodeoxycholic acid 
(TDCA), glycocholic acid (GCA), glycolithocholic acid (GLCA), glycoursodeoxycholic 
acid (GUDCA), glycochenodeoxycholic acid (GCDCA), and glycodeoxycholic acid 
(GDCA). Samples were heated for one hour at 70°C with orbital shaking at 900 RPM. Solids 
were precipitated by centrifugation at 17000 RCF for 15 minutes at 4°C. Supernatants were 
decanted as 10% of the original sample (e.g. 100 µL of a 1 mL extraction sample) and 
evaporated at approximately 100 mTorr at RT on a rotovap (Centrivap Concentrator 
#7810016, Labconco, Kansas City, MO, USA). The evaporated samples were reconsistuted 
at 100x dilution from the original sample (e.g. 100 µL decanted solution is resuspended at 1 
mL) in 20% acetonitrile, 80% water with 0.1% formic acid. 
Due to small volumes, gall bladder bile samples were first diluted in 10 volumes of 100% 
ethanol (#3916EA, Decon Labs, King of Prussia, PA, USA). The ethanol-based dilutions 
were combined with 9 volumes of ultrapure water (Invitrogen) and subjected to extraction as 
above. 
Each 10 µL extracted and reconsistuted sample injection was analyzed on a Waters Acquity 
UPLC coupled to a Xevo-qTOF Mass Spectrometer (Waters, Manchester, UK) using an 
Acquity UPLC HSS T3 1.8 micron, 2.1 × 100 mm column (# 186003539) and Acquity UPLC 
HSS T3 1.8 micron Guard Column (# 186003976). Needle wash was two parts isopropanol, 
one part water, and one part acetonitrile. Purge solvent was 5% acetonitrile in water. A 
pooled quality control sample was run every 8 injections to correct for drift in response. 
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Mass spectrometer instrument parameters were as follows: Capillary Voltage 2.4 kV, 
Collision Energy 6.0 eV, Sampling Cone 90V, Source Offset 40 V, Source 120 °C, 
desolvation gas temperature 550 °C, cone gas 50 L/Hr, and desolvation Gas 900 L/Hr. Time-
of-flight mass spectra were collected in resolution mode, corresponding to 30000 m/Δm. The 
mass axis was calibrated with sodium formate clusters and locked using leucine enkephalin. 
A seven point external calibration curve was collected three times within the run from 0.05 
to 30 µM of the bile acid standards [0.05, 0.1, 0.5, 1, 5, 10, 30 µM]. External standards were 
taurocholic acid (TCA), tauro-alpha-muricholic acid (TαMCA), tauro-beta-muricholic acid 
(TβMCA), tauro-omega-muricholic acid (TωMCA), tauro-hyocholic acid (THCA), tauro-
deoxycholic acid (TDCA), tauro-ursodeoxycholic acid (TUDCA), tauro-chenodeoxycholic 
acid (TCDCA), taurolithocholic acid (TLCA), glyco-cholic acid (GCA), glyco-hyocholic 
acid (GHCA), glyco-deoxycholic acid (GDCA), glyco-hyodeoxycholic acid (GHDCA), 
cholic acid (CA), alpha-muricholic acid (αMCA), beta-muricholic acid (βMCA), omega-
muricholic acid (ωMCA), hyocholic acid (HCA, also known as γ-muricholic acid), 
deoxycholic acid (DCA), chenodeoxycholic acid (CDCA), ursodeoxycholic acid (UDCA), 
hyodeoxycholic acid (HDCA), murocholic acid (murideoxycholic acid, MDCA), lithocholic 
acid (LCA), glycolithocholic acid (GLCA), glycourosodeoxycholic acid (GUDCA), and 
glycochenodeoxycholic acid (GCDCA). It was not possible to resolve UDCA and HDCA; 
so the sum was reported. 
Integrated areas of extracted ion chromatograms were obtained using QuanLynx (Waters, 
Milford, MA, USA) and a mass extraction window of 10 mDa. Final corrections accounting 
for drift in instrumental sensitivity were performed in Microsoft Excel. 
 
Elution Gradient 
Samples were eluted using the following gradient of water with 0.1% formic acid (“A”) and 
balance of acetonitrile with 0.1% formic acid: 
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1. 0 min, 0.55 mL/min at 68% A 
2. 2 min, 0.55 mL/min at 60% A, 10 curve 
3. 5 min, 0.55 mL/min at 40% A, 5 curve 
4. 6 min, 1.1 mL/min at 0% A, 10 curve  
5. 6.2 min, 1.2 mL/min at 0% A, 6 curve 
6. 6.5 min, 1.47 mL/min at 0% A, 6 curve 
7. 8.9 min, 1.5 mL/min at 0% A, 6 curve 
8. 9.0 min, 0.9 mL/min at 68% A, 6 curve 
9. 10 min, 0.55 mL/min at 68% A, 6 curve 
 
Bile acid data processing: 
Bile acid data analysis was performed using the tools described in “Sequencing data 
processing.”  
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Fig. 2S1. Tail cup design and experimental setup for preventing coprophagy. (A, B, C) 
Functional (TC-F, left) and mock (TC-M, right) tail cups as viewed from different 
perspectives. (D) The standard cages with wire mesh floors used in this study (WF). (E, F) 
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Ventral view of the functional (TC-F; left) and mock (TC-M, right) tail cups 24 hours after 
emptying (TC-F) or mock emptying (TC-M).  
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Fig. 2S2. Mounting of functional tail cups onto mice. (A, B) Ventral and dorsal view of 
the tail sleeve mounted at the tail base. (C, D) Ventral and dorsal view of the functional tail 
cup installed and locked in place using the tail sleeve.  
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Fig. 2S3. Body weight changes across all groups of mice in relation to food intake over 
the course of the study. (A) Body weights of each individual animal at the beginning and at 
the endpoint of the study. (B) Normalized food intake per gram of body weight per day 
measured over the entire duration of the study. Multiple comparisons of the normally-
distributed homoscedastic data were performed using one-way ANOVA; pairwise 
comparisons were performed using the Student’s t-test with FDR correction. N = 6 mice per 
group. 
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Fig. 2S4. Quantification of the culturable microbial load and microbiota profile along 
the entire GIT of mice fitted with functional tail cups (TC-F) and control mice (CTRL). 
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(A) Culturable microbial loads in contents along the gastrointestinal tract were evaluated 
using the most probable number (MPN) assay performed in anaerobic BHI-S broth (N = 5 
mice per group, P-values were calculated using the Wilcoxon–Mann–Whitney test). (B) 
PCA analysis of the CLR-transformed relative microbial abundance profiles (16S rRNA 
gene amplicon sequencing) along the entire GIT in TC and CT mice (N = 1 mouse from each 
group).  
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Fig. 2S5. Bile acid profiles in gallbladder bile and in lumenal contents along the entire 
GIT. (A) The fraction of secondary bile acids (conjugated + unconjugated) in gallbladder 
bile and throughout the GIT (STM = stomach; SI1 = upper third of the small intestine (SI), 
SI2 = middle third or the SI, SI3 = lower third of the SI roughly corresponding to the 
duodenum, jejunum, and ileum respectively; CEC = cecum; COL = colon). In all plots, 
individual data points are overlaid onto box-and-whisker plots; whiskers extend from the 
quartiles (Q2 and Q3) to the last data point within 1.5 × interquartile range (IQR). Multiple 
comparisons were performed using the Kruskal–Wallis test; pairwise comparisons were 
performed using the Wilcoxon–Mann–Whitney test with FDR correction. N = 6 mice per 
group. 
 
  
63 
 
Table 2S1. Primer oligonucleotide sequences used in the study. [NNNNNNNNNNNN] – 12-base barcode sequences “806rcbc” 
according to [3]. 
Primer Oligonucleotide sequence Assay Reference 
UN00F2 CAGCMGCCGCGGTAA 16S rRNA gene DNA qPCR 
16S rRNA gene DNA 
ddPCR 
[49] 
UN00R0 GGACTACHVGGGTWTCTAAT [1], [3] 
UN00F2_BC AATGATACGGCGACCACCGA GATCTACACTATGGTAATTGT CAGCMGCCGCGGTAA 16S rRNA gene DNA 
amplicon barcoding 
[49] 
UN00R0_BC 
CAAGCAGAAGACGGCATACGAGAT 
[NNNNNNNNNNNN] AGTCAGTCAGCC 
GGACTACHVGGGTWTCTAAT 
[1], [3] 
ILM00F(P5) AATGATACGGCGACCACCGA Barcoded amplicon and 
NGS library quantification 
ddPCR 
[1], [3], 
[147]–[149]ILM00R(P7) CAAGCAGAAGACGGCATACGA 
Seq_UN00F2_Read_1 TATGGTAATTGTCAGCMGCCGCGGTAA MiSeq read 1 [49] 
Seq_UN00R0_Read_2 AGTCAGTCAGCCGGACTACHVGGGTWTCTAAT MiSeq read 2 [1], [3] 
Seq_UN00R0_RC_Ind
ex ATTAGAWACCCBDGTAGTCCGGCTGACTGACT MiSeq index read [1], [3] 
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Table 2S2. Thermocycling parameters for the quantitative PCR (qPCR) assay for 16S 
rRNA gene DNA copy quantification. 
Step Repeats Temperature, °C Time, sec 
Initial denaturation × 1 95 120 
Cycle × 40 
95 15 
53 10 
68 45 
 
 
Table 2S3. Thermocycling parameters for the digital PCR (dPCR) assay for absolute 
16S rRNA gene DNA copy quantification. 
Step Repeats Temperature, °C Time, sec Ramp, °C/sec
Initial denaturation × 1 95 300 2.0 
Cycle × 40 
95 30 2.0 
52 30 2.0 
68 60 2.0 
Dye stabilization × 1 
4 300 2.0 
90 300 2.0 
12 ∞ 2.0 
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Table 2S4. Thermocycling parameters for the 16S rRNA gene DNA amplicon 
barcoding PCR reaction for next generation sequencing (NGS). 
Step Repeats Temperature, °C Time, sec 
Initial denaturation × 1 94 180 
Cycle × var. 
94 45 
54 60 
72 105 
Final extension × 1 72 600 
 
 
Table 2S5. Thermocycling parameters for the digital PCR (dPCR) assay for barcoded 
amplicon and Illumina NGS library quantification. 
Step Repeats Temperature, °C Time, sec Ramp, °C/sec
Initial denaturation × 1 95 300 2.0 
Cycle × 40 95 30 2.0 60 90 2.0 
Dye stabilization × 1 
4 300 2.0 
90 300 2.0 
12 ∞ 2.0 
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Table 2S6. Reagents and chemical standards used in the bile acid metabolomics assay. 
Bile acid Reference # Vendor LOT 
TαMCA C1893-000 Steraloids B1439 
TβMCA C1899-000 Steraloids B1594 
TωMCA C1889-000 Steraloids B1731 
THCA C1887-000 Steraloids B1621 
αMCA C1890-000 Steraloids B1529 
βMCA C1895-000 Steraloids B1725 
ωMCA C1888-000 Steraloids B1710 
HCA (gMCA) C1850-000 Steraloids B0696 
HDCA C0860-000 Steraloids B0684 
MCA C0910-000 Steraloids B1711 
GDCA C1087-000 Steraloids B2122 
GCA C1927-000 Steraloids   
GHDCA C0865-000 Steraloids B1667 
GHCA C1860-000 Steraloids L1105 
TCA 13232UNL Isosciences EH1-2015-111A1 
CA 13098UNL Isosciences EH1-2014-075A1 
DCA 13100UNL Isosciences EH1-2014-076A1 
TCDCA 13105UNL Isosciences EH1-2015-110A1 
TDCA 13225UNL Isosciences EH1-2015-112A1 
TUDCA 13106UNL Isosciences EH1-2014-027A1 
TLCA 13230UNL Isosciences EH1-2014-077A1 
CDCA 13101UNL Isosciences PG1-2014-149A1 
UDCA 13102UNL Isosciences EH1-2015-113A1 
LCA 13099UNL Isosciences EH1-2014-030A1 
D4-TCA 13232 Isosciences SJ5-2015-035A1 
D4-DCA 13100 Isosciences RS6-2014-168A1 
D4-CA 13098 Isosciences SJ5-2015-100A1 
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D4-TDCA 13225 Isosciences SJ5-2015-034A1 
D4-GLCA 13231 Isosciences SR3-2015-203A1 
D4-GUDCA 13224 Isosciences SJ5-2017-206A1 
D4-GCDCA 13104 Isosciences SJ4-2012-070A1 
D4-GCA 13443 Isosciences SJ5-2015-118A1 
D4-GDCA 13226 Isosciences SJ5-2015-033A1 
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AVAILABILITY OF DATA AND MATERIAL 
Sequencing data (paired end reads in FASTQ) and a manifest file for analysis in Qiime2 are 
available under a CC-BY license via CaltechDATA: http://dx.doi.org/10.22002/D1.1295. 
Supplementary Information includes a zip file containing all sequencing sample metadata, 
numerical microbial quantification data (16S copies from the main study + MPN from the 
pilot study), Qiime2 sequencing output data, PICRUSt2 output data, numerical bile acid 
analysis data, numerical body weight data, numerical food intake data, and analytical scripts 
(iPython Notebooks) for all figures and statistical analyses in the manuscript. 
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